Navigation Links
Mayo Clinic Proceedings reviews deep brain stimulation to treat psychiatric diseases
Date:6/29/2009

ROCHESTER, Minn. Pioneering therapeutic trials to investigate the effectiveness of deep brain stimulation (DBS) in hard-to-treat depression, obsessive-compulsive disorder (OCD) and Tourette's syndrome are underway at multiple medical centers around the world, according to a review in the June 2009 issue of Mayo Clinic Proceedings. "Deep brain stimulation has long been seen as valuable for controlling movement disorders," according to the review, written by Susannah Tye, Ph.D., Mark Frye, M.D., from the Mayo Clinic Department of Psychiatry and Psychology, and Kendall Lee, M.D., Ph.D., Mayo Clinic Department of Neurosurgery. "It now is being investigated for hard-to-treat psychiatric disorders," according to the authors.

"Early results indicate the effect on depression and obsessive compulsive disorder is beneficial, but the therapy needs further study," Dr. Lee says. The potential for this breakthrough treatment is enormous in reducing the toll of mental illness on patients, their families and society, according to the review.

Unlike electroshock therapy (ECT), which stimulates the entire brain, DBS stimulates specific parts of the brain. DBS is thought to be functionally equivalent to creating a lesion on the brain, but with the advantage of being adjustable and reversible.

"It is like implanting a pacemaker for the brain," says Dr. Lee. The patient is awake during deep brain stimulation surgery while a neurosurgeon implants the electrodes. Patients are able to give immediate feedback. Additionally, patients do not feel any pain during the implantation procedure since the brain is without pain receptors.

In the developed world, major depression is second only to cardiovascular disease in premature mortality and time lived with disability according to the review. In persons aged 15 to 44 years, depression is the most disabling medical illness in the United States. The prevalence of major depression, known to be a c
'/>"/>

Contact: John Murphy
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
2. OpusClinicalSuite(R) Achieves 08 CCHIT Certification as Inpatient EHR
3. Clinical Study Data Indicates that Celliant Reduces Pain
4. DaVita Celebrates the Opening of Its 1,500th Outpatient Kidney Care Clinic in the United States
5. Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery
6. MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009
7. Heritage Summit HealthCare Inc. Contracts with Mayo Clinic for Workers Compensation Care
8. MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans
9. Living Cell Technologies Diabetes Clinical Trial Authorized by New Zealand Government
10. Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over-the-Road Professionals
11. Caregivers at Alameda County Clinic to Strike Over Bad-Faith Bargaining by Clinic Management

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...on,s largest network of Hispanic health advocates ...rm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-U...atives showed they have heard the voice of America...for America Act. Now the Senate must deliver, with...e reform," said Dr. Jane L. Delgado, President and...
(Date:11/8/2009)...NGTON, Nov. 8 The follo..., Operation Rescue Insurrecta Nex. ,, Mr. Terr...been fighting to keep child-killing by abortion ou...rry states: "This is a great first step to victory...e a lot of fighting ahead of us. Our rejoicing mus...
(Date:11/8/2009)...WOOD, Calif., Nov. 8 Ma...of Babies luncheon to recognize prominent individu...n and who are role models for March of Dimes commi... the March of Dimes November Prematurity Awareness...re urged to join the fight for preemies! ,, (Ph...
(Date:11/7/2009)...ON, Nov. 7 The American...James, Director of Health at the Family Violence P...d Service today at its semi-annual policy-making m... the highest honor the AMA House of Delegates best...ww.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...
(Date:11/7/2009)...NGTON, Nov. 7 With the ...ichoice extremists are holding the entire bill hos...e demanding that the bill go far beyond the status...orated into the original bill. In an outrageous a...aturday afternoon, antichoice Democrats are demand...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Family Violence Prevention Expert 2
...out to find about the efficacy of the musical rhyt...rch being conducted at the Methodist Neurological ...lp and could be a better alternative for treating ...Tintner, a neurologist at the Methodist NI, is stu...
...of studies has found that herbals like of devil's ...ghly beneficial for treating shot-term low back pa...effective as pain medication and is found to be be...k pain. The authors looked at randomized con...
...genetic disorder. Statistics show that in India ab...It is characterised severe mucosal bleeding as a r... It is predominantly seen affecting the male popul...lly die of internal bleeding. In order to prevent ...
...ed the largest outbreak of mumps over the past two...s country since 1988 // , is believed to have begu...e federal officials reported yesterday that the ou...an 1,000 cases reported so far, most of them, abou...
...le gender bias prevailing against women, especiall... the field of medical surgery that inhibits free-f...e cons, that invariably steers them to opt out of ...ession of the ‘right surgical personality’, which ...
...Royal Victorian Eye and Ear Hospital in East Melbo... need not be treated by patching the eye.// Doing ... pain, a new review of several studies has found. ...on to do so,” Turner said. Dr Turner and a colleag...
Other Medicine News:Health News:Herbal Preparation Effective For Treating Short Term Low-Back Pain 2Health News:Mumps Outbreak In The US 2Health News:Mumps Outbreak In The US 3Health News:Misplaced Bravado: A Career In Surgery Eludes Women? 2
(Date:11/6/2009)...re/ -- , - Trial Will Compare NXL103 With... Multi-Resistant Staphylococcus Aureus (MRSA) Infe...ical company focused on the discovery and,developm...significant global,problem of microbial resistance...bacterial NXL103 (flopristin/linopristin), has sta...
(Date:11/5/2009)... Transcept Pharmaceutical...al company focused on the development and commerci...ortant therapeutic needs in the field of neuroscie...leconference with management to discuss third quar...2, 2009, at 5:00 p.m. Eastern Standard Time. Fina...
(Date:11/5/2009)...wswire/ -- Renee Cobos, MD, a board certified derm...t the University of California, Irvine, announced ...s results with Thermage CPT®. The updated sys...touring, features a new vibrating hand piece that ...comfort. ,, "Thermage has always been popular ...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 1NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 2NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 3NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 4Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 1Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 2Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 3Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 4Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 5Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 6Sex Hormone Protein May Predict Type 2 Diabetes 53775 1Sex Hormone Protein May Predict Type 2 Diabetes 53775 2Sex Hormone Protein May Predict Type 2 Diabetes 53775 3
...Inc. (NHSi) has won a two-year award of $1.9 milli...te of the National Institutes of Health (NIH) to d..., The project aims to develop the Hemanext Anaero...y blood for transfusion therapy and extends the sh...demonstrated that this new technology can deliver ...
...urysm patients treated with coil embolization comp...26 Boston Scientific Corporation (NYSE: BSX ) t... clinical trial in The Lancet Neurology showing pa...ed with endovascular coil embolization are 23 perc...to patients who undergo surgical clipping. The fi...
Other Medicine Technology:Bethesda-Based NHSi Wins $2M Grant for Blood Technology 2Bethesda-Based NHSi Wins $2M Grant for Blood Technology 3Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 2Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 3Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 4
Gamma GT (Modified IFCC)
Triglycerides GPO-PAP (DIMENSION®)
Triglycerides
Creatine Kinase (CK-MB) Control
Medicine Products: